Review Article - (2014) Volume 3, Issue 2

Molecular Advances Leading to Treatment Implications for Fragile X Premutation Carriers

Jonathan Polussa1,2, Andrea Schneider1,2 and Randi Hagerman1,2*
1Medical Investigation of Neurodevelopmental Disorders (MIND) Institute, University of California Davis Health System, Sacramento, California, USA, E-mail: jonathan.polussa@ucdmc.ucdavis.edu
2Department of Pediatrics, University of California Davis Health System, Sacramento, California, USA, E-mail: jonathan.polussa@ucdmc.ucdavis.edu
*Corresponding Author: